Cargando…
Fallacies of Using the Win Ratio in Cardiovascular Trials: Challenges and Solutions
The win ratio was introduced into cardiovascular trials as a potentially better way of analyzing composite endpoints to account for the hierarchy of clinical significance of their components and to facilitate the inclusion of recurrent events. The basic concept of the win ratio is to define a hierar...
Autores principales: | Ajufo, Ezimamaka, Nayak, Aditi, Mehra, Mandeep R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322884/ https://www.ncbi.nlm.nih.gov/pubmed/37426527 http://dx.doi.org/10.1016/j.jacbts.2023.05.004 |
Ejemplares similares
-
The Maximum Entropy Fallacy Redux?
por: Aurell, Erik
Publicado: (2016) -
Statistical fallacies & errors can also jeopardize life & health of many
por: Indrayan, Abhaya
Publicado: (2018) -
CARD9-Mediated Signaling and Cardiovascular Diseases
por: Liu, Xuanyou, et al.
Publicado: (2022) -
Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process
por: Schwartz, Jonathan G., et al.
Publicado: (2016) -
Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease: Insights From the Oncology Drug Development Experience
por: Khakoo, Aarif Y., et al.
Publicado: (2019)